Close this search box.

We are creating some awesome events for you. Kindly bear with us.

NTU Singapore Study: Insights on AI Trust in Healthcare

Getting your Trinity Audio player ready...

Artificial intelligence has impacted many aspects of medicine, promising accurate diagnoses, better management decisions, and improved outcomes for both patients and healthcare systems. However, the successful implementation of AI technology in clinical practice hinges on the trust and acceptance of healthcare providers.

A recent international study led by NTU Singapore, focusing on the treatment of digestive diseases, provides insight into the levels of trust and acceptance among doctors in the gastroenterology field. The study surveyed 165 gastroenterologists and gastrointestinal surgeons in the Asia-Pacific region, revealing significant findings about their perceptions of AI in medical practice.

The research team found that 80% of respondents accept and trust the use of AI-powered tools for diagnosing and assessing colorectal polyps, benign growths in the colon that could become cancerous. Additionally, 70% expressed trust in AI-assisted applications that guide endoscopists on whether to remove polyps during screening colonoscopies.

Interestingly, the study noted no significant differences in acceptance levels based on gender, type of healthcare setting (public vs. private), or size of the medical practice (large hospital units vs. small group practices). However, experience level played a crucial role in acceptance. Contrary to expectations, gastroenterologists with fewer than 10 years of clinical experience perceived a higher risk associated with AI-powered medical tools compared to their more seasoned colleagues with over 10 years of experience.

Published in the scientific journal JMIR AI in March, these findings underscore the need for further research into the factors influencing doctors’ acceptance of AI in their medical practice. The study highlights the importance of addressing concerns and providing comprehensive training to build confidence in AI tools among less experienced doctors. By fostering trust and acceptance, the medical community can fully harness the potential of AI to enhance patient care and optimise healthcare outcomes.

NTU Singapore stands at the forefront of innovation in the medical and healthcare fields, leveraging cutting-edge technology including AI, robotics, and pioneering research to drive advancements and improve patient outcomes.

In a significant development, an international team of scientists has engineered a flexible electrode, inspired by spider silk, that moulds around muscles, nerves, and hearts, outperforming conventional electrodes in electrical stimulation and signal recording.

This innovation could revolutionise biomedical devices for monitoring irregular heartbeats, repairing nerves, and reducing scars. The electrode, crafted from moisture-responsive material, fits seamlessly around tissues, providing higher sensitivity and minimally invasive installation.

In another breakthrough, NTU researchers developed a cutting-edge method to treat glioblastoma using a significantly reduced dose of X-rays. This innovative radiodynamic therapy employs a novel compound, the molecular radio afterglow dynamic probe (MRAP), which targets brain tumour cells with minimal side effects.

MRAPs absorb X-rays and release cancer-killing free radicals selectively, showing remarkable efficacy in mouse experiments. This technology offers a safer, more effective brain cancer treatment, with potential advancements in targeting tumour cells and incorporating immunotherapeutic functions.

Singapore has established itself as a global leader in biomedical sciences, driven by a commitment to research, digital transformation, and cutting-edge technologies. This success is underpinned by a collaborative ecosystem of government support, business partnerships, and a focus on excellence.

Significant R&D investment, exemplified by the RIE2025 plan, has fostered strategic alliances, attracted top talent, and spurred groundbreaking drug development in Singapore. Its strategic location, sustained R&D efforts, and collaborative approach have attracted biotech startups and venture funding. Key initiatives like the Experimental Drug Development Centre (EDDC) and international partnerships have achieved major milestones in drug discovery. With a focus on precision medicine and leveraging its diverse population for genetic research, Singapore is poised to become a regional biomedical hub.

Proactive government initiatives and a vibrant startup community drive tech leadership, particularly in AI and blockchain, positioning Singapore at the forefront of global tech advancement.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


As a Titanium Black Partner of Dell Technologies, CTC Global Singapore boasts unparalleled access to resources.

Established in 1972, we bring 52 years of experience to the table, solidifying our position as a leading IT solutions provider in Singapore. With over 300 qualified IT professionals, we are dedicated to delivering integrated solutions that empower your organization in key areas such as Automation & AI, Cyber Security, App Modernization & Data Analytics, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Renowned for our consulting expertise and delivering expert IT solutions, CTC Global Singapore has become the preferred IT outsourcing partner for businesses across Singapore.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and consulting services provider, helping clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,800 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently, and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity, and service. For more information, visit